1. Canadian Depo-Provera label updated with risk of BMD loss

   Media release 21 January 2013 Pages: 2 - 2

2. Health Canada reports suspected ADRs with cimicifuga

   News item 21 January 2013 Pages: 2 - 2

3. Vioxx may return to Canadian market if requested?

   Media release 21 January 2013 Pages: 2 - 2

4. Canadian requirements for WBC monitoring with Clozaril use remain

   Media release 21 January 2013 Pages: 3 - 3

5. Health Canada: reports of Duragesic patch abuse

   News item 21 January 2013 Pages: 3 - 3

6. Health Canada: reports of Stevens-Johnson syndrome with ibuprofen

   News item 21 January 2013 Pages: 3 - 3

7. US Duragesic labelling to reflect that of other CII products

   News item 21 January 2013 Pages: 3 - 3

8. US Viagra, Cialis and Levitra labels to include reports of vision loss

   Media release 21 January 2013 Pages: 3 - 3

9. Glucocorticoids: greater AE costs

   Clinical study 21 January 2013 Pages: 4 - 4

10. Increase in deaths from abuse of fentanyl patches

    Media release 21 January 2013 Pages: 4 - 4

11. Ocular adverse effects with tolterodine and oxybutynin

    Clinical study 21 January 2013 Pages: 4 - 4

12. Psychotropic use associated with increased mortality in dementia

    Clinical study 21 January 2013 Pages: 4 - 4

13. Glucosamine increases insulin resistance

    Clinical study 21 January 2013 Pages: 5 - 5

14. Greater cancer-related mortality risk with sulphonylureas alone than metformin ± sulphonylureas

    Clinical study 21 January 2013 Pages: 5 - 5

15. One-year changes in bodyweight vary with different antihyperglycaemics

    Clinical study 21 January 2013 Pages: 5 - 5

16. Some NSAIDs may increase breast cancer risk

    Clinical study 21 January 2013 Pages: 5 - 5

17. Antiretrovirals

    Case report 21 January 2013 Pages: 6 - 6

18. Asparaginase

    Case report 21 January 2013 Pages: 6 - 6

19. Baclofen overdose

    Case report 21 January 2013 Pages: 6 - 6

20. BCG vaccine

    Case report 21 January 2013 Pages: 6 - 7

21. Botulinum toxin A

    Case report 21 January 2013 Pages: 7 - 7

22. Clozapine

    Case report 21 January 2013 Pages: 7 - 7

23. Dextromethorphan abuse

    Case report 21 January 2013 Pages: 7 - 7

24. Ethinylestradiol/cyproterone

    Case report 21 January 2013 Pages: 7 - 8

25. Ethionamide

    Case report 21 January 2013 Pages: 8 - 8

26. Ezetimibe

    Case report 21 January 2013 Pages: 8 - 8

27. Gemcitabine interaction

    Case reports 21 January 2013 Pages: 8 - 9

28. Glimepiride

    Case report 21 January 2013 Pages: 9 - 10

29. Imatinib

    Case report 21 January 2013 Pages: 10 - 10

30. Infliximab

    Case report 21 January 2013 Pages: 10 - 10

31. Infliximab

    Case reports 21 January 2013 Pages: 10 - 11

32. Interferon-α-2a/interferon-α-2b

    Case reports 21 January 2013 Pages: 11 - 11

33. Irbesartan/hydrochlorothiazide

    Case report 21 January 2013 Pages: 11 - 11

34. Levofloxacin interaction

    Case report 21 January 2013 Pages: 11 - 12

35. Lidocaine

    Case report 21 January 2013 Pages: 12 - 12

36. Linezolid

    Case report 21 January 2013 Pages: 12 - 12

37. Loperamide

    Case report 21 January 2013 Pages: 12 - 12

38. Mefloquine

    Case report 21 January 2013 Pages: 13 - 13

39. Mesalazine

    Case report 21 January 2013 Pages: 13 - 13

40. Mirtazapine

    Case report 21 January 2013 Pages: 13 - 13

41. Perindopril

    Case report 21 January 2013 Pages: 13 - 14

42. Propranolol

    Case report 21 January 2013 Pages: 14 - 14

43. Quetiapine withdrawal

    Case report 21 January 2013 Pages: 14 - 14

44. Rosiglitazone

    Case report 21 January 2013 Pages: 14 - 14

45. Thalidomide

    Case report 21 January 2013 Pages: 14 - 15